Health Care & Life Sciences » Pharmaceuticals | Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc. | Ownership

Companies that own Aclaris Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Franklin Advisers, Inc.
2,944,646
9.51%
388,555
0.03%
06/30/2018
Deerfield Management Company LP
2,745,705
8.86%
0
1.25%
06/30/2018
Fidelity Management & Research Co.
2,171,594
7.01%
663,584
0%
06/30/2018
BlackRock Fund Advisors
2,149,642
6.94%
199,038
0%
06/30/2018
Polar Capital LLP
1,650,715
5.33%
0
0.06%
06/30/2018
D. E. Shaw & Co. LP
1,268,915
4.09%
30,629
0.03%
06/30/2018
The Vanguard Group, Inc.
1,148,784
3.71%
25,517
0%
06/30/2018
FIAM LLC
957,181
3.09%
117,781
0.03%
06/30/2018
Citadel Advisors LLC
868,230
2.8%
-28,607
0.02%
06/30/2018
Rock Springs Capital Management LP
856,000
2.76%
326,000
0.5%
06/30/2018

About Aclaris Therapeutics

View Profile
Address
640 Lee Road
Malvern Pennsylvania 19087
United States
Employees -
Website http://www.aclaristx.com
Updated 07/08/2019
Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address unmet needs in medical and aesthetic dermatology and immunology. It operates thrpough Dermatology Therapeutics and Contract Research segments. The Dermatology Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.